$52 Million Invested in Hearing Disorder Research and Drug Development Startup

A startup called Decibel Therapeutics has been formed to focus on discovering and developing new medicines to protect, repair and restore hearing. Their first program will involve an antibody to help grow neurites (a portion of the nerve that extends to other nerves). Charles Liberman, a renowned Harvard researcher who has directly and indirectly contributed to Hyperacusis research, is a founding member. Related research of his on hidden hearing loss found neurotrophins can help restore damage of the auditory nerve.

News Article
Company Press Release

From hyperacusisresearch.org facebook page

Leave a Reply

Your email address will not be published. Required fields are marked *